April 21, 2010
BTCI, Madison, WI
Note: All speakers listed are confirmed
| 7:45-8:30 | REGISTRATION |
| 8:30-8:40 | Welcome: Robert N. Golden, M.D., Dean, School of Medicine & Public Health, University of Wisconsin-Madison & Carl E. Gulbrandsen, Ph.D., J.D., Director, Wisconsin Alumni Research Foundation |
| 8:40-9:20 | Human embryonic stem cells: commitment, adaptation and cancer: Peter Andrews, Ph.D.,, Arthur Jackson Professor of Medical Science, University of Sheffield |
| 9:20-10:00 | Integrating cell banking, characterization, and cGMP production efforts to support the efficient translation of stem cell therapeutics into clinical trials: Derek Hei, Ph.D., Technical Director, Waisman Clinical Biomanufacturing Facility and Principal Investigator, National Stem Cell Bank, University of Wisconsin-Madison |
| 10:00-10:20 | BREAK AND POSTER VIEWING |
| 10:20-11:00 | Bioprocessing for growth and differentiation of stem cells: Peter Zandstra, Ph.D.,, Professor and Canada Research Chair of Stem Cell Bioengineering, University of Toronto |
| 11:00-11:40 | Pre-clinical animal studies: Raymond Lund, Ph.D., Professor, Casey Eye Institute, Oregon Health Science University |
| 11:40-1:00 | LUNCH AND POSTER VIEWING |
| 1:00-1:40 | FDA requirements for products derived from stem cells: Brent McCright, Ph.D., Research Biologist, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration |
| 1:40-2:20 | Clinical trials for cell therapies: cell delivery and in vivo imaging technologies: Amish Raval, M.D., Assistant Professor, School of Medicine & Public Health, University of Wisconsin – Madison |
| 2:20-2:400 |
BREAK AND POSTER VIEWING |
| 2:40-3:20 | Development of human embryonic stem cells for therapeutic applications: Thomas B. Okarma, Ph.D., M.D., President, Chief Executive Officer, Geron |
| 3:20-4:00 | Bench to bedside: Stratatech’s path to clinical evaluation: Lynn Allen-Hoffmann, PhD., CEO and President, Stratatech Corporation and Professor, Department of Pathology and Laboratory Medicine, University of Wisconsin – Madison |
| 4:00-4:40 | PANEL: What are the Next Steps? Challenges and Innovations on the Road to Stem Cell Applications: Linda F. Hogle,Ph.D., Associate Professor, Medical History & Bioethics, University of Wisconsin–Madison (Moderator) and Invited Speakers |
| 4:40-5:00 | Concluding comments: Tim Kamp, MD, Ph.D., Director, Stem Cell & Regenerative Medicine Center, University of Wisconsin–Madison |
| 5:00-6:00 | RECEPTION |